IL123725A0 - Labelled biotin derivatives - Google Patents

Labelled biotin derivatives

Info

Publication number
IL123725A0
IL123725A0 IL12372598A IL12372598A IL123725A0 IL 123725 A0 IL123725 A0 IL 123725A0 IL 12372598 A IL12372598 A IL 12372598A IL 12372598 A IL12372598 A IL 12372598A IL 123725 A0 IL123725 A0 IL 123725A0
Authority
IL
Israel
Prior art keywords
biotin derivatives
labelled biotin
labelled
derivatives
biotin
Prior art date
Application number
IL12372598A
Other languages
English (en)
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Publication of IL123725A0 publication Critical patent/IL123725A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12372598A 1995-09-18 1998-03-18 Labelled biotin derivatives IL123725A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95202512 1995-09-18

Publications (1)

Publication Number Publication Date
IL123725A0 true IL123725A0 (en) 1998-12-06

Family

ID=8220642

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12372598A IL123725A0 (en) 1995-09-18 1998-03-18 Labelled biotin derivatives

Country Status (7)

Country Link
EP (1) EP0857071A1 (xx)
JP (1) JPH11513374A (xx)
CA (1) CA2232411A1 (xx)
CZ (1) CZ75498A3 (xx)
IL (1) IL123725A0 (xx)
NO (1) NO981202L (xx)
WO (1) WO1997010854A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU699216B2 (en) * 1995-06-07 1998-11-26 Immunomedics Inc. Improved delivery of diagnostic and therapeutic agents to a target site
CA2373993C (en) * 1999-05-25 2008-11-18 Barnes-Jewish Hospital Site specific binding system, nuclear imaging compositions and methods
US7371579B1 (en) * 1999-07-01 2008-05-13 The University Of Maryland Nickel-based reagents for detecting DNA and DNA-protein contacts
ITRM20010079A1 (it) * 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
CN101932722A (zh) * 2007-12-05 2010-12-29 伦敦王室学院 方法和组合物
CN102336908B (zh) * 2010-07-20 2013-07-03 中国科学院上海应用物理研究所 一种99mTc配合物、其制备方法、中间体及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds

Also Published As

Publication number Publication date
NO981202D0 (no) 1998-03-17
JPH11513374A (ja) 1999-11-16
CZ75498A3 (cs) 1999-09-15
WO1997010854A1 (en) 1997-03-27
MX9802107A (es) 1998-08-30
EP0857071A1 (en) 1998-08-12
CA2232411A1 (en) 1997-03-27
NO981202L (no) 1998-05-18

Similar Documents

Publication Publication Date Title
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en) Glucoxide derivatives
ZA969990B (en) Oxymethoxy-3-aryl-pyrone derivatives
ZA96228B (en) Indolepiperidine derivatives
ZA969278B (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
HU9600107D0 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
HK1003299A1 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA964470B (en) Cycloalkane-benzylidene derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
IL123725A0 (en) Labelled biotin derivatives
ZA96629B (en) 4-Aminobenzolylguanidine derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
GB9512530D0 (en) Decals
PL324892A1 (en) Aza-antracyclinone derivatives
ZA967204B (en) Alkenyl-benzoylguanidine derivatives
GR3036344T3 (en) 4-mercapto-benzoylguanidine derivatives